Research grade and pharmaceutical quality are different claims
Why a purity percentage cannot stand in for a manufacturing system, approved formulation, or intended use.
Two vials can carry similar purity numbers and still have very different documentation, manufacturing controls, and permitted uses. Terms such as research grade and pharmaceutical grade need to be unpacked into specific, verifiable claims. A single analytical result is too narrow to establish the quality system behind an entire product.
Define the claim before comparing products
For research work, suitability depends on the experiment and the material specification. A biochemical assay may require a different impurity assessment from a sensitive cell system. A seller's grade label does not tell you whether those requirements were considered. Ask for the actual identity, content, impurity, and stability evidence relevant to the study instead of treating a marketing category as a complete specification.
Manufacturing controls extend beyond testing
FDA Q7 describes GMP expectations for active pharmaceutical ingredients, including an appropriate quality system. That framework covers more than final purity: controlled processes, documented responsibilities, and management of quality are part of the picture. A research certificate does not demonstrate that the manufacturer follows that system. Nor does an API quality claim by itself establish that a finished product has regulatory approval.
Separate identity, purity, and formulation
Identity asks whether the expected material is present. A chromatographic purity result describes a method-defined comparison of signals. An assay or content measurement asks how much material is present on a stated basis. Formulation adds another set of questions about excipients, concentration, container, and stability. If two reports measure different properties, comparing their percentages as though they were a single grade is misleading.
Use the right conclusion
A research purchaser can conclude that a specified sample met a specified requirement when the evidence supports it. That conclusion should name the requirement and preserve its limitations. It should not expand into a claim that the material is a medicine, interchangeable with an approved product, sterile, or suitable for administration. Write the acceptance decision narrowly enough that another researcher can see exactly what was established and what remains unknown.
Sources and further reading
M Bio research journal. Educational material for laboratory research; not a protocol for human or animal use.